HVAD: The ENDURANCE Supplemental Trial
Carmelo A. Milano(Duke University Hospital), Francis D. Pagani(Michigan Medicine), Nir Uriel(New York Proton Center), Claudius Mahr(Medical City Dallas Hospital), Emma J. Birks(Lung Institute), Jeffrey S. Miller(Science Museum of Minnesota), Thomas A. Vassiliades(Medtronic (United States)), Valluvan Jeevanandam(University of Chicago), Antone Tatooles(Rush University Medical Center), Keith D. Aaronson(University of Michigan), David W. Markham(Saint Joseph's Hospital), Joseph G. Rogers(Baylor College of Medicine), Nahush A. Mokadam(University of Washington), Geetha Bhat(Christ Hospital), Mark S. Slaughter(University of Louisville)
Cited by 223
Related Papers
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter
|American Journal of Transplantation|2020|837
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711